News
3hon MSNOpinion
Voices: Serena Williams’s GLP-1 partnership marks a disturbing cultural turning point
COMMENT: As a Black woman in a white-dominated sport, Williams experienced unique pressures. Yet to see someone of her ...
“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...
Fox News senior medical analyst Dr. Marc Siegel joins 'Fox News Live' to discuss how tennis icon Serena Williams was able to ...
Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...
1hon MSN
Serena Williams lost 14 kg using GLP-1 drug: 8 things to know about the weight loss medication
Tennis champion Serena Williams has caused a stir after revealing that using GLP-1 medication has been key to her weight-loss ...
People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using metformin, a new study has found.
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may ...
Dr. Tim Church predicted recently that GLP-1 agonists, GLP-1 /GIP agonists and similar prescription drugs will soon be as much a part of the medication infrastructure as statins or thyroid pills.
Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts promoting their use outside of care for diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results